Helena A. Yu
- Pulmonary and Respiratory Medicine top 0.1%
- Oncology top 0.2%
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Gregory J. RielyMark G. KrisMarc LadanyiMaria E. ArcilaNatasha RekhtmanCamelia S. SimaWilliam PaoVincent A. Miller
- Topics
- Lung Cancer Treatments and Mutations (174 papers)Lung Cancer Research Studies (70 papers)Colorectal Cancer Treatments and Studies (57 papers)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Helena A. Yu
180 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Pulmonary and Respiratory Medicine 6.6k
- Oncology 5.5k
- Molecular Biology 3.1k
- Cancer Research 2.0k
- Pathology and Forensic Medicine 591
Countries citing papers authored by Helena A. Yu
This map shows the geographic impact of Helena A. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena A. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena A. Yu more than expected).
Fields of papers citing papers by Helena A. Yu
This network shows the impact of papers produced by Helena A. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena A. Yu. The network helps show where Helena A. Yu may publish in the future.
Co-authorship network of co-authors of Helena A. Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Helena A. Yu. A scholar is included among the top collaborators of Helena A. Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena A. Yu. Helena A. Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 1 | |
| 9 | 28 | |
| 10 | 26 | |
| 11 | Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTONbreakdown → | 95 |
| 12 | 29 | |
| 13 | 47 | |
| 14 | 82 | |
| 15 | 31 | |
| 16 | 230 | |
| 17 | 188 | |
| 18 | 317 | |
| 19 | 23 | |
| 20 | Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skippingbreakdown → | 423 |
About Helena A. Yu
Helena A. Yu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 195 papers that have together received 8.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (174 papers), Lung Cancer Research Studies (70 papers) and Colorectal Cancer Treatments and Studies (57 papers). The work is most often cited by research in Oncology (5.5k citations), Pulmonary and Respiratory Medicine (6.6k citations) and Cancer Research (2.0k citations). Helena A. Yu has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Gregory J. Riely, Mark G. Kris, Marc Ladanyi, Maria E. Arcila, Natasha Rekhtman, Camelia S. Sima, William Pao, Vincent A. Miller, Maureen F. Zakowski and Charles M. Rudin. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.